Archive - March 2018
Potential new approach to the treatment of multiple sclerosis
Biogen, AbbVie pull MS drug from the market
Aurobindo injectables facility hit with 483 due to cleanliness
Novavax’s flu vaccine for older adults shows early promise against Sanofi’s Fluzone
U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease
Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse
Ortho Dermatologics Announces U.S. FDA Filing Acceptance for Jemdel Plaque Psoriasis Treatment
FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation